PATENT CLAIM ANALYSIS

Application Number: 16272108
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "282000"]

Abstract:
Provided herein, generally, are pharmaceutical formulations, e.g., injectable pharmaceutical formulations with improved stability, comprising morphine sulfate or a hydrate thereof, and methods of producing and using the same. Also provided herein are kits comprising the formulations, e.g., injectable morphine formulations.

Claim (Index 53):
The formulation of  claim 50 , wherein the isotonic agent is selected from sodium chloride, calcium chloride, potassium chloride, sodium bicarbonate, sodium lactate, Ringer's solution, dextrose, lactose, mannitol, glucose, glycerine, dextran, Normosol R, saline, Hartmann's solution, and mixtures and combinations thereof.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14887803', '14715277', '14207245', '15375784', '14968351']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8068634986562927
- 35 USC 102 Novelty (BERT): 0.636485614592097
- Combined Prediction Score: 0.7898257102498731
- Mean Citation Score: 476.58007
- Max Citation Score: 626.95123
- Similarity Product: 532.9156605966997

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test